IN2014DN10904A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10904A
IN2014DN10904A IN10904DEN2014A IN2014DN10904A IN 2014DN10904 A IN2014DN10904 A IN 2014DN10904A IN 10904DEN2014 A IN10904DEN2014 A IN 10904DEN2014A IN 2014DN10904 A IN2014DN10904 A IN 2014DN10904A
Authority
IN
India
Prior art keywords
viruses
lymphotropism
dna
pcr
lymphocyte
Prior art date
Application number
Other languages
English (en)
Inventor
Nariman Gulyamov
Original Assignee
Obschestvo S Ogranichennoi Otvetstvennostyu New Medical Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoi Otvetstvennostyu New Medical Technologies filed Critical Obschestvo S Ogranichennoi Otvetstvennostyu New Medical Technologies
Publication of IN2014DN10904A publication Critical patent/IN2014DN10904A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN10904DEN2014 2012-06-18 2013-05-21 IN2014DN10904A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UZIA20120233 2012-06-18
PCT/UZ2013/000001 WO2013192636A1 (ru) 2012-06-18 2013-05-21 Способ оценки жизнеспособности вирусов, обладающих лимфотропизмом

Publications (1)

Publication Number Publication Date
IN2014DN10904A true IN2014DN10904A (xx) 2015-09-11

Family

ID=84083119

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10904DEN2014 IN2014DN10904A (xx) 2012-06-18 2013-05-21

Country Status (10)

Country Link
US (7) US9879329B2 (xx)
EP (3) EP3517628A1 (xx)
KR (2) KR20160139059A (xx)
CN (1) CN104066848A (xx)
AP (1) AP2014008052A0 (xx)
EA (1) EA032036B1 (xx)
IL (1) IL235962B (xx)
IN (1) IN2014DN10904A (xx)
WO (1) WO2013192636A1 (xx)
ZA (1) ZA201405954B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3517628A1 (en) * 2012-06-18 2019-07-31 Mkrtchyan, Ovik Leonardovich Method for evaluation of viability of viruses with lymphotropism properties

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674680A (en) * 1994-01-31 1997-10-07 The Rockefeller University Methods for the prognosis and monitoring of AIDS
US20090176202A1 (en) * 2007-03-23 2009-07-09 Rigel Pharmaceuticals, Inc. Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV
EP3517628A1 (en) * 2012-06-18 2019-07-31 Mkrtchyan, Ovik Leonardovich Method for evaluation of viability of viruses with lymphotropism properties

Also Published As

Publication number Publication date
IL235962B (en) 2018-07-31
CN104066848A (zh) 2014-09-24
EP2818558A1 (en) 2014-12-31
US9873922B2 (en) 2018-01-23
US9879329B2 (en) 2018-01-30
US20180245167A1 (en) 2018-08-30
EP3517627A1 (en) 2019-07-31
US9957579B2 (en) 2018-05-01
ZA201405954B (en) 2015-11-25
US20200190606A1 (en) 2020-06-18
KR20160139059A (ko) 2016-12-06
US11505837B2 (en) 2022-11-22
EA201401097A1 (ru) 2015-04-30
EP3517628A1 (en) 2019-07-31
EP2818558B1 (en) 2019-07-17
AP2014008052A0 (xx) 2014-11-30
KR20140127864A (ko) 2014-11-04
US20160369325A1 (en) 2016-12-22
IL235962A0 (en) 2015-01-29
US10570466B2 (en) 2020-02-25
US20170073779A1 (en) 2017-03-16
EA032036B1 (ru) 2019-03-29
US20150125852A1 (en) 2015-05-07
WO2013192636A1 (ru) 2013-12-27
US20210140001A1 (en) 2021-05-13
US20230078548A1 (en) 2023-03-16
EP2818558A4 (en) 2015-09-23
US10920289B2 (en) 2021-02-16

Similar Documents

Publication Publication Date Title
Bignami et al. Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1
Schulz et al. Low thymic activity and dendritic cell numbers are associated with the immune response to primary viral infection in elderly humans
Monaco et al. Immune system involvement in the pathogenesis of JC virus induced PML: what is learned from studies of patients with underlying diseases and therapies as risk factors
Pawełczyk et al. Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+
Leisching et al. The association of OASL and type I interferons in the pathogenesis and survival of intracellular replicating bacterial species
JP2015512255A5 (xx)
Gravel et al. Cell culture systems to study human herpesvirus 6A/B chromosomal integration
Manjunath et al. Comparative and temporal transcriptome analysis of peste des petits ruminants virus infected goat peripheral blood mononuclear cells
Michaud et al. Understanding the role of the immune system in the development of cancer: New opportunities for population-based research
Pedersen et al. Developing new TB biomarkers, are miRNA the answer?
IN2014DN03409A (xx)
Ouedraogo et al. Comparison of EBV DNA viral load in whole blood, plasma, B‐cells and B‐cell culture supernatant
Bent et al. Enriching pathogen transcripts from infected samples: a capture-based approach to enhanced host–pathogen RNA sequencing
IN2014DN10904A (xx)
CN103820574A (zh) 人疱疹病毒6型实时荧光定量pcr分型检测试剂盒
Upadhyay et al. TREM2+ and interstitial macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques
Ckumdee et al. Development of a rapid and sensitive DNA turbidity biosensor test for diagnosis of katG gene in isoniazid resistant Mycobacterium tuberculosis
Trottier et al. Detection of Epstein–Barr virus in leucoreduced blood products
Berger et al. Redefining de novo gammaherpesvirus infection through high-dimensional, single-cell analysis of virus and host
Gossner et al. Cell-based screen identifies human type I interferon-stimulated regulators of Toxoplasma gondii Infection
RU2012144762A (ru) Способ тестирования вируса лейкоза крупного рогатого скота с использованием пцр-диагностики с флуоресцентной формой детекции
CN102816844B (zh) Pcr-焦磷酸法检测金黄色葡萄球菌的检测引物、试剂盒和检测方法
CN102851361B (zh) 沙门氏菌、肠炎沙门氏菌和鼠伤寒沙门氏菌pcr-焦磷酸法的检测引物、试剂盒和检测方法
Brinkmann et al. Understanding Host–Virus Interactions: Assessment of Innate Immune Responses in Mastomys natalensis Cells after Arenavirus Infection. Viruses 2022, 14, 1986
Dahal Analysis of host microRNAs as potential biomarkers of Hendra virus disease in horses